Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypertension × Lisinopril × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Lymphoma, Follicular 1 Hypertension 1 Dyspnea 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

relacorilant 4 Hydrochlorothiazide 4 Nutrition Assessment 2 Labetalol 2 Bevacizumab 2 Angiotensin-Converting Enzyme Inhibitors 2 Amlodipine 2 ziprasidone 1 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 fimasartan 1 enzalutamide 1 clevidipine 1 bicalutamide 1 aliskiren 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1 Therapeutics 1 Surveys and Questionnaires 1 Sunitinib 1 Sulindac 1 Spironolactone 1 Sevelamer 1 Rocuronium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡